Joshua Halpern, MD, MS
- Regional Medical Director and Chief Scientific Officer
- Board-Certified, Fellowship-Trained Male Reproductive Urologist
- Locations: New York, New Jersey, Delaware, Pennsylvania, Connecticut and Vermont
Male Fertility and Reproductive Urology Specialist Serving the Northeast
Joshua Halpern, MD, MS, is a board-certified, fellowship-trained male reproductive urologist specializing in male infertility, vasectomy reversal, varicocele repair, and surgical sperm retrieval. As Posterity Health’s Regional Medical Director for the Northeast, Dr. Halpern provides specialized male fertility and reproductive urology care to patients across New York, New Jersey, Delaware, Pennsylvania, Connecticut, and Vermont. He also serves as Posterity Health’s Chief Scientific Officer and is a faculty member at Northwestern University Feinberg School of Medicine.
Dr. Halpern earned his medical degree from Weill Cornell Medicine and completed a six-year urology residency at NewYork-Presbyterian/Weill Cornell Medical Center in New York City. He then completed fellowship training in Andrology and Male Infertility at Northwestern University Feinberg School of Medicine, where he remained in practice before joining Posterity Health. He also earned a Master of Science in Health Policy and Economics from Weill Cornell Medicine.
As a male fertility specialist serving the Northeast, Dr. Halpern helps men and couples get clear answers about the factors affecting their fertility and understand the treatment options available to them. His approach combines a thorough evaluation with personalized, data-driven guidance designed to help patients move forward with confidence.
He works closely with reproductive endocrinologists (REIs) and fertility centers throughout the region to provide integrated care for couples on their path to parenthood. Through Posterity Health’s national care model, patients across the Northeast can access specialized reproductive urology expertise and a streamlined path to the care they need.
Dr. Halpern is also dedicated to advancing the science of male fertility. He has extensive research experience, has received multiple research grants, and has served as principal investigator on multiple clinical trials. As Chief Scientific Officer at Posterity Health, he helps translate research, clinical experience, and insights from male fertility care into better-informed care for patients.
“I think about a good male fertility evaluation as three parts: a good physical exam, blood work, and a semen test—and helping people understand, ‘Hey, that’s it.’”
Areas of Expertise
- Male infertility and microsurgery
- Surgical sperm retrieval (TESE, PESA, TESA)
- Microdissection testicular sperm extraction (microTESE)
- Microepididymal sperm aspiration (MESA)
- Vasectomy reversal
- Varicocele repair
- Hormone therapy
- Testosterone replacement therapy (TRT)
Education & Training
- Doctor of Medicine - Weill Cornell Medical College (New York, NY)
- Master of Science (Health Policy and Economics) - Weill Cornell School of Graduate Medical Sciences (New York, NY)
- Intern, Surgery - Department of Surgery, Weill Cornell Medicine New York Presbyterian Hospital (New York, NY)
- Resident, Urology - Department of Urology, Weill Cornell Medicine New York Presbyterian Hospital (New York, NY)
- Fellow, Andrology - Department of Urology, Northwestern University Feinberg School of Medicine (Chicago, IL)
Locations
- New York
- New Jersey
- Delaware
- Pennsylvania
- Connecticut
- Vermont
Awards & Recognition
- Award 1
In the News
- New York Times | Article | New Erectile Dysfunction Treatment Cleared for Over-the-Counter U.S. Sales
- NBC News | Article | No increased heart risks with testosterone replacement therapy, study finds
- Urology Times | Interview | Joshua Halpern, MD, MS, on the clinical role of mail-in semen analysis
- Scientific American | Article | The Truth about Testosterone
- New York Times | Article | Are Men Getting Duped Seeking Out Testosterone Tests?
- SART Fertility Experts | Podcast | Azoospermia
- Better Edge | Podcast | Alternatives to Testosterone Replacement Therapy
- F&S Reports | Article | Reviewers of the Year 2025–2026. F&S Reports celebrates excellence in our world-class reviewers
More From Dr. Halpern

The Future of Male Fertility is Arriving Faster Than Ever

The Two-Year Infertility Journey That Doesn’t Have to Take Two Years
